BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22969091)

  • 21. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand.
    Ohno T; Shirakami Y; Shimizu M; Kubota M; Sakai H; Yasuda Y; Kochi T; Tsurumi H; Moriwaki H
    Cancer Lett; 2012 Oct; 323(2):215-22. PubMed ID: 22579649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway.
    Fujino T; Murakami K; Ozawa I; Minegishi Y; Kashimura R; Akita T; Saitou S; Atsumi T; Sato T; Ando K; Hara S; Kikugawa K; Hayakawa M
    FEBS J; 2009 Mar; 276(5):1319-32. PubMed ID: 19187229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
    Journe F; Laurent G; Chaboteaux C; Nonclercq D; Durbecq V; Larsimont D; Body JJ
    Breast Cancer Res Treat; 2008 Jan; 107(1):49-61. PubMed ID: 17333335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
    Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
    J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
    Manov I; Pollak Y; Broneshter R; Iancu TC
    FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
    Wang X; Lu R; Fang JY
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Peng J; Liu K
    Biochem Pharmacol; 2014 Nov; 92(2):289-98. PubMed ID: 25278094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
    Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Farnesoid X receptor regulates the growth of renal adenocarcinoma cells without affecting that of a normal renal cell-derived cell line.
    Fujino T; Sakamaki R; Ito H; Furusato Y; Sakamoto N; Oshima T; Hayakawa M
    J Toxicol Sci; 2017; 42(3):259-265. PubMed ID: 28496032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
    J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism.
    Ma XN; Liu XY; Yang YF; Xiao FJ; Li QF; Yan J; Zhang QW; Wang LS; Li XY; Wang H
    Biochem Biophys Res Commun; 2011 Jul; 410(4):803-8. PubMed ID: 21703232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells.
    Liu XC; Lian W; Zhang LJ; Feng XC; Gao Y; Li SX; Liu C; Cheng Y; Yang L; Wang XJ; Chen L; Wang RQ; Chai J; Chen WS
    PLoS One; 2015; 10(8):e0136215. PubMed ID: 26292095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of genes involved in the regulation of p16 in psoriatic involved skin.
    Mark EB; Jonsson M; Asp J; Wennberg AM; Mölne L; Lindahl A
    Arch Dermatol Res; 2006 Apr; 297(10):459-67. PubMed ID: 16552541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
    Zheng D; Hu Z; He F; Gao C; Xu L; Zou H; Wu Z; Jiang X; Wang J
    Oncol Rep; 2014 Jul; 32(1):411-8. PubMed ID: 24807674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1-ERK1/2-p70S6K signalling pathway.
    Leung TH; Yam JW; Chan LK; Ching YP; Ng IO
    Liver Int; 2010 Oct; 30(9):1315-23. PubMed ID: 20629949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
    Kim YJ; Jung JK; Lee SY; Jang KL
    Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice.
    Borude P; Edwards G; Walesky C; Li F; Ma X; Kong B; Guo GL; Apte U
    Hepatology; 2012 Dec; 56(6):2344-52. PubMed ID: 22730081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.